Alternatively, pharmacological inhibition of FAO using the inhibitor of CPT1, the rate-limiting enzyme in FAO cycle, can restore the function of tumour effector T cells but block the production of inhibitory cytokines from MDSC, consequently leading to a delay of tumour growth in vivo in tumour-bearing mice (94, 130). Here, CPT1A is linked to neoplasm.